These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5780193)

  • 1. The role of aminogenic glucagon secretion in blood glucose homeostasis.
    Unger RH; Ohneda A; Aguilar-Parada E; Eisentraut AM
    J Clin Invest; 1969 May; 48(5):810-22. PubMed ID: 5780193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.
    Ohneda A; Parada E; Eisentraut AM; Unger RH
    J Clin Invest; 1968 Oct; 47(10):2305-22. PubMed ID: 5676526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effect of secretin upon pancreatic alpha cell function.
    Santeusanio F; Faloona GR; Unger RH
    J Clin Invest; 1972 Jul; 51(7):1743-9. PubMed ID: 4555784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man.
    Wise JK; Hendler R; Felig P
    J Clin Invest; 1973 Nov; 52(11):2774-82. PubMed ID: 4748510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous and amino acid-stimulated glucagon secretion in the immediate postnatal period. Relation to glucose and insulin.
    Sperling MA; DeLamater PV; Phelps D; Fiser RH; Oh W; Fisher DA
    J Clin Invest; 1974 Apr; 53(4):1159-66. PubMed ID: 4815080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.
    Unger RH; Ketterer H; Dupré J; Eisentraut AM
    J Clin Invest; 1967 Apr; 46(4):630-45. PubMed ID: 4290022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alanine on glucagon secretion.
    Müller WA; Faloona GR; Unger RH
    J Clin Invest; 1971 Oct; 50(10):2215-8. PubMed ID: 5116210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs.
    Adrogué HJ; Chap Z; Ishida T; Field JB
    J Clin Invest; 1985 Mar; 75(3):798-808. PubMed ID: 3884666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Schneider V; Karam JH; Noacco C
    J Clin Invest; 1974 May; 53(5):1284-9. PubMed ID: 4825225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of experimental insulin deficiency on glucagon secretion.
    Müller WA; Faloona GR; Unger RH
    J Clin Invest; 1971 Sep; 50(9):1992-9. PubMed ID: 4935445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis.
    Sherwin R; Wahren J; Felig P
    Metabolism; 1976 Nov; 25(11 Suppl 1):1381-3. PubMed ID: 979638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.